Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

PANDEMIC HIGHLIGHTS U.S. PHARMA’S CHINA DEPENDENCE

China supplies more than 90 percent of the hydrocortisone, antibiotics, and antibiotic ingredients consumed in the U.S. as well as 70 percent of the ibuprofen and large proportions of other drugs and nutritional supplements, according to the Council on Foreign Relations.
The COVID-19 pandemic has stirred concerns about the U.S.’s ability to sustain its pharmaceutical supply in the case of global emergency or worsening relations with China.
“If China shut the door on exports of core components to make our medicines, within months our pharmacy shelves would become bare and our health care system would cease to function,” said Rosemary Gibson of the Hastings Center and author of a book on the subject.
That scenario may be tested now. Last week, India, which imports drug ingredients from China and exports finished medicines, ordered its pharma companies to halt exports of 26 drugs and drug ingredients, most of them antibiotics.
Germany, South Korea, Taiwan, and other countries supplying surgical masks and related supplies also are restricting exports to ensure adequate supplies at home.
“The coronavirus shows the importance of bringing all of that manufacturing back to America,” Donald Trump said last week.
Some of that manufacturing already has left China. But, it has resettled in countries such as Mexico and Vietnam, where costs are low. Many drugs now being made in the U.S. are still being made from Chinese ingredients.
China has sought to capitalize on the U.S.’s dependence, with Xinhua, the state news agency, declaring that instead of blaming China for starting the coronavirus pandemic, the world should thank it for supplying medicines. If China stopped exporting drugs, it said, “the U.S. would sink into the hell of a novel coronavirus epidemic.”
TREND FORECAST: The United States will attempt to take measures to produce drugs, as they once did, in their homeland. If fact, it will become a political issue as well and part of a platform among the candidates in 2020’s Presidential Reality Show.®
 
 

Comments are closed.